Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole versus letrozole + dexamethasone in women with polycystic ovarian syndrome undergoing ovulation induction and IUI
IRCT20170315033085N4Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of letrozole and dexamethasone in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Luteinizing hormone level, Estradiol level and 3 more. Started Apr 2013; status: completed.
02
Drugs
letrozoledexamethasone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20170315033085N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170315033085N4.